Abstract
Advancing neuroblastoma care: future horizons after approval of eflornithine by FDA.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International journal of surgery (London, England)
Paper Title
Journal
Date
